| Oct 10 |
Here’s Why BeiGene, Ltd. (BGNE) Rallied in Q3
|
| Oct 7 |
BeiGene (BGNE) Moves 5.3% Higher: Will This Strength Last?
|
| Oct 6 |
US Listed Chinese Stocks Dominate Another Week - Li Auto, JD.com Among Top 10 Large Cap Gainers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?
|
| Oct 4 |
Chinese biotechs gain as drugmakers targeted in new security bill said to mull divestments
|
| Sep 27 |
3 Stocks That May Be Trading Below Intrinsic Value By Up To 48.2%
|
| Sep 26 |
BeiGene Provides Update on FDA Advisory Committee Vote on Benefit-Risk Profile of PD-1 Inhibitors, including TEVIMBRA®, for Treatment of ESCC and Gastric/GEJ Cancers
|
| Sep 26 |
Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
|
| Sep 25 |
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
|
| Sep 20 |
High Growth Tech Stocks To Watch In September 2024
|
| Sep 18 |
BeiGene initiated at outperform at JMP Securities on strength of Brukinsa
|
